ARCHIVES

Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently

This article is from The Cancer Letter archive.

Vol. 38 No. 08 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

Kansas City Clinic Settles Medicare Overbilling Claim

June 6, 2014

CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years

April 16, 1999

Zerhouni forms steering committee; Olden to retire.

August 1, 2003

In Brief: Ford Decides Against Asking For Recision Of NCI Funds After Congress Overrides Verto

October 8, 1976

NCAB Committee Approved Concepts For D Contracts

December 7, 1984